Pneumoperitoneum with carbon dioxide inhibits macrophage tumor necrosis factor-α secretion: Source of transitional-cell carcinoma port-site metastasis, with prophylactic irrigation strategies to decrease laparoscopic oncologic risks

Journal of Endourology

Volumn 22, Issue 1, 2008, Pages 105-111

  Ost, Michael C ^a   Patel, Keyur P ^a   Rastinehad, Ardeshir R ^a   Chu, Pui Yan ^a   Anderson, Ann E ^a   Smith, Arthur D ^a   Lee, Benjamin R ^a  

^a LONG ISLAND JEWISH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON DIOXIDE; HEPARIN; LIPOPOLYSACCHARIDE; POVIDONE IODINE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLADDER TUMOR; CANCER RISK; CONTROLLED STUDY; FEMALE; IMMUNOASSAY; LAPAROSCOPIC SURGERY; METASTASIS; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PNEUMOPERITONEUM; PRIORITY JOURNAL; SKIN INCISION; TRANSITIONAL CELL CARCINOMA; TUMOR VOLUME;

ANIMALS; ANTI-INFECTIVE AGENTS, LOCAL; ANTIBIOTICS, ANTINEOPLASTIC; CARBON DIOXIDE; CARCINOMA, TRANSITIONAL CELL; CELL LINE, TUMOR; FEMALE; HEPARIN; IRRIGATION; LAPAROSCOPY; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED C57BL; MITOMYCIN; NEOPLASM SEEDING; PNEUMOPERITONEUM, ARTIFICIAL; POVIDONE-IODINE; TUMOR NECROSIS FACTOR-ALPHA; URINARY BLADDER NEOPLASMS;

EID: 38349126480     PISSN: 08927790     EISSN: None     Source Type: Journal    
DOI: 10.1089/end.2007.9858     Document Type: Article

References (21)

1. Ong AM, Bhayani SB, Pavlovich CP. Trocar site recurrence after laparoscopic nephroureterectomy. J Urol 2003;170:1301.
2. El-Tabey NA, Shoma A. Port site metastases after robot-assisted laparoscopic radical cystectomy. Urology 2005;66:1110.e1-e3.
3. Ost MC, Tan BJ, Lee BR. Urological laparoscopy: Basic physiological considerations and immunological consequences. J Urol 2005;174:1183-1188.
4. Bariol SV, Stewart GD, McNeill SA, Tolley DA. Oncological control following laparoscopic nephroureterectomy: 7-year outcome. J Urol 2004;172:1805-1808.
5. Cathelineau X, Arroyo C, Rozet F, Barret E, Vallancien G. Laparoscopic assisted radical cystectomy: The montsouris experience after 84 cases. Eur Urol 2005;47:780-784.
6. Finelli A, Gill IS, Desai MM, Moinzadeh A, Magi-Galluzzi C, Kaouk JH. Laparoscopic extended pelvic lymphadenectomy for bladder cancer: Technique and initial outcomes. J Urol 2004;172:1809-1812.
7. Matin SF, Gill IS. Recurrence and survival following laparoscopic radical nephroureterectomy with various forms of bladder cuff control. J Urol 2005;173:395-400.
8. Mydlo JH, Weinstein R, Shah S, Solliday M, Macchia RJ. Long-term consequences from bladder perforation and/or violation in the presence of transitional cell carcinoma: Results of a small series and a review of the literature. J Urol 1999;161:1128-1132.
9. El-Hakim A, Chiu KY, Sherry B, Bhuiya T. Smith AD, Lee BR. Peritoneal and systemic inflammatory mediators of laparoscopic bowel injury in a rabbit model. J Urol 2004;172;1515-1519.
10. Ost MC, Tan BJ, Smith AD, Lee BR. A model for transitional cell carcinoma port site metastasis. J Endourol 2005;19(suppl 1):A144.
11. Goldstein DS, Lu ML, Hattori T, Ratliff TL, Loughlin KR, Kavoussi LR. Inhibition of peritoneal tumor-cell implantation: model for laparoscopic cancer surgery. J Endourol 1993;7:237-241.
12. Eshraghi N, Swanstrom LL, Bax T, Jobe B, Horvath K, Sheppard B, Deveney C. Topical treatments of laparoscopic port sites can decrease the incidence of incision metastasis. Surg Endosc 1999;13:1121-1124.
13. 2 causes peritoneal acidosis independent of systemic pH. J Gastrointest Surg 2005;9:1245-1252.
14. Neuhaus SJ, Watson DI, Ellis T, Rofe AM, Jamieson CG. The effect of immune enhancement and suppression on the development of laparoscopic port site metastases. Surg Endosc 2000;14:439-443.
15. Curet MJ. Port site metastases. Am J Surg 2004;187:705-712.
16. Lee BR, Tan BJ, Smith AD. Laparoscopic port site metastases: Incidence, risk factors, and potential preventive measures. Urology 2005;65:639-644.
17. Rassweiler J, Tsivian A, Kumar AV, Lymberakis C, Schulze M, Seeman O, Frede T. Oncological safety of laparoscopic surgery for urological malignancy: Experience with more than 1,000 operations. J Urol 2003;169:2072-2075.
18. Micali S, Celia A, Bove P, De Stefani S, Sighinolfi MC, Kavoussi LR, et al. Tumor seeding in urological laparoscopy: An international survey. J Urol 2004;171:2151-2154.
19. Muntener M, Schaeffer EM, Romero FR, et al. Incidence of local recurences and port site metastasis after laparoscopic radical nephroureterectomy. J Urol 2006;174(suppl 4): 359.
20. Hoffstetter W, Ortega A, Chiang M, Paik P, Beart RW. Effects of topical tumoricidal agents on port-site recurrence of colon cancer: An experimental study in rats.. J Laparoendosc Adv Surg Tech A 2001;11:9-12.
21. Braumann C, Ordemann J, Wildbrett P, Jacobi CA. Influence of intraperitoneal and systemic application of taurolidine and taurolidine/heparin during laparoscopy on intraperitoneal and subcutaneous tumour growth in rats. Clin Exp Metastasis 2000;18:547-552.